Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Advanced Endoscopic Imaging Modalities

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT02799771Completed

HYPID (Pulmonary Hypertension in Interstitial Lung Disease) EXTENSION

NCT02380326UnknownPrimary

Innovation in Endobronchial Sampling

NCT01443598Completed

Pulmonary Hypertension in Interstitial Lung Disease

Showing all 3 trials

Research Network

Common Treatments

  • Advanced Endoscopic Imaging Modalities1

Active Sponsors

  • Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires2
  • Hospices Civils de Lyon2
  • KU Leuven1

Top Investigators

Related Conditions

  • Pulmonary Arterial Hypertension2

Activity Timeline